M IT 200mg Tablet contains Itraconazole 200mg, a broad-spectrum triazole antifungal agent indicated for the treatment of various systemic and superficial fungal infections. Itraconazole exerts its antifungal activity by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a critical component of fungal cell membranes. Disruption of ergosterol synthesis results in increased membrane permeability and ultimately fungal cell death. This medication is effective against infections caused by dermatophytes, yeasts, and molds, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. M IT 200mg Tablet is administered orally, with dosing regimens tailored according to the type and severity of infection. It is important to take the tablet with food to enhance absorption. Caution is advised in patients with hepatic impairment or congestive heart failure, and periodic monitoring of liver function tests is recommended during prolonged therapy. Potential drug interactions should be carefully reviewed due to itraconazole’s inhibition of cytochrome P450 enzymes. Common adverse effects include gastrointestinal disturbances, headache, and rash. M IT 200mg Tablet should be used under medical supervision to ensure efficacy and safety.